The Department of Veterans Affairs (VA) recently issued a final rule amending its regulations regarding access to VA facilities by pharmaceutical company representatives. As discussed in the Federal Register preamble to the final rule, the amended regulations are intended to reduce or eliminate any potential for disruption in the patient care environment, manage activities and promotions at VA facilities, and provide pharmaceutical company representatives with a consistent standard of permissible business practices at VA facilities. The new rule, which focuses on permissible promotional practices for drugs and drug-related supplies, is limited in scope to “on-site, in-person” promotional and educational visits to VA medical facilities by pharmaceutical company representatives. The rule becomes effective April 4, 2012.
Click the link below to read the full alert.